Preferred Label : Anti-4-1BB/PD-L1 Bispecific Antibody BH3120;
NCIt synonyms : 4-1BB x PD-L1 Bispecific Antibody BH3120; PD-L1/4-1BB BsAb BH3120; Anti-PD-L1/4-1BB Bispecific Antibody BH3120; Anti-4-1BB/Anti-PD-L1 Monoclonal Antibody BH3120;
NCIt definition : A heterodimeric immunoglobulin (IgG)-like bispecific antibody, with biased binding
affinities, targeting human programmed death-ligand 1 (PD-L1; cluster of differentiation
274; CD274) and 4-1BB (CD137; tumor necrosis factor receptor superfamily member 9;
TNFRSF9), with potential checkpoint inhibitory, immunostimulating and antineoplastic
activities. Upon administration, anti-4-1BB/PD-L1 bispecific antibody BH3120 simultaneously
targets and binds with its anti-4-1BB arm and with moderate affinity to 4-1BB, which
is expressed on a variety of leukocyte subsets including activated T-lymphocytes,
and, with its anti-PD-L1 arm with high affinity to PD-L1, which is expressed on tumor
cells. Upon PD-L1 binding and PD-L1-mediated cross-linking, the 4-1BB activation signal
is induced and BH3120 acts as a conditional 4-1BB agonist in the tumor microenvironment
(TME), resulting in T-cell co-stimulation and enhances T-lymphocyte-mediated anti-tumor
activity. At the same time, BH3120 prevents PD-L1 from binding to and activating its
receptor, programmed cell death 1 (PD-1; PDCD1; CD279; programmed death-1). This abrogates
T-cell inhibition, activates antigen-specific T-lymphocytes and enhances cytotoxic
T-cell-mediated tumor cell lysis, which may lead to a reduction in tumor growth. PD-L1
binding to PD-1 on activated T-cells inhibits the expansion and survival of CD8-positive
T-cells, suppresses the immune system and results in immune evasion. 4-1BB, a surface
glycoprotein of the tumor necrosis factor receptor superfamily, is an inducible costimulatory
receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.;
Molecule name : BH 3120; BH-3120;
NCI Metathesaurus CUI : CL1927047;
Origin ID : C204839;
UMLS CUI : C5908069;
Semantic type(s)
chemical_or_drug_has_mechanism_of_action
concept_is_in_subset
has_target